LYEL
Lyell Immunopharma·NASDAQ
--
--(--)
--
--(--)
6.55 / 10
Outperform
Lyell Immunopharma demonstrates positive fundamental quality with a 6.5/10 score. Key strengths include high PB-ROE (10.7026, Group 1) and Asset-MV (-0.5007, Group 4), both historically associated with strong returns (11.47% and 14.99% one-month returns, respectively). Gross profit margin is an impressive 100%, placing it in the top quartile. However, current assets turnover (0.0001) and fixed assets turnover (0.0007) are subpar, ranking in Group 1 with negative historical returns (-1.88% and -1.64%, respectively), which drags down the overall fundamental score. Balanced by these factors, the company earns an Outperform rating but requires improvement in asset utilization efficiency.
Analysis Checks(7/10)
Revenue-MV
Value-10.48
Score2/3
Weight16.98%
1M Return11.69%
Value-10.48
Score2/3
Weight16.98%
1M Return11.69%
Gross profit margin (%)
Value100.00
Score3/3
Weight14.95%
1M Return10.80%
Value100.00
Score3/3
Weight14.95%
1M Return10.80%
PB-ROE
Value10.70
Score3/3
Weight17.50%
1M Return11.47%
Value10.70
Score3/3
Weight17.50%
1M Return11.47%
Fixed assets turnover ratio
Value0.00
Score1/3
Weight-1.77%
1M Return-1.64%
Value0.00
Score1/3
Weight-1.77%
1M Return-1.64%
Cash-MV
Value-0.07
Score2/3
Weight11.16%
1M Return7.73%
Value-0.07
Score2/3
Weight11.16%
1M Return7.73%
Inventory turnover ratio
Value47.85
Score3/3
Weight6.54%
1M Return5.26%
Value47.85
Score3/3
Weight6.54%
1M Return5.26%
Profit-MV
Value0.46
Score2/3
Weight11.14%
1M Return7.79%
Value0.46
Score2/3
Weight11.14%
1M Return7.79%
Current assets turnover ratio
Value0.00
Score0/3
Weight-2.04%
1M Return-1.88%
Value0.00
Score0/3
Weight-2.04%
1M Return-1.88%
Asset-MV
Value-0.50
Score3/3
Weight25.86%
1M Return14.99%
Value-0.50
Score3/3
Weight25.86%
1M Return14.99%
Net profit / Total profit (%)
Value100.00
Score0/3
Weight-0.33%
1M Return-0.30%
Value100.00
Score0/3
Weight-0.33%
1M Return-0.30%
Revenue-MV
Value-10.48
Score2/3
Weight16.98%
1M Return11.69%
Value-10.48
Score2/3
Weight16.98%
1M Return11.69%
Inventory turnover ratio
Value47.85
Score3/3
Weight6.54%
1M Return5.26%
Value47.85
Score3/3
Weight6.54%
1M Return5.26%
Gross profit margin (%)
Value100.00
Score3/3
Weight14.95%
1M Return10.80%
Value100.00
Score3/3
Weight14.95%
1M Return10.80%
Profit-MV
Value0.46
Score2/3
Weight11.14%
1M Return7.79%
Value0.46
Score2/3
Weight11.14%
1M Return7.79%
PB-ROE
Value10.70
Score3/3
Weight17.50%
1M Return11.47%
Value10.70
Score3/3
Weight17.50%
1M Return11.47%
Current assets turnover ratio
Value0.00
Score0/3
Weight-2.04%
1M Return-1.88%
Value0.00
Score0/3
Weight-2.04%
1M Return-1.88%
Fixed assets turnover ratio
Value0.00
Score1/3
Weight-1.77%
1M Return-1.64%
Value0.00
Score1/3
Weight-1.77%
1M Return-1.64%
Asset-MV
Value-0.50
Score3/3
Weight25.86%
1M Return14.99%
Value-0.50
Score3/3
Weight25.86%
1M Return14.99%
Cash-MV
Value-0.07
Score2/3
Weight11.16%
1M Return7.73%
Value-0.07
Score2/3
Weight11.16%
1M Return7.73%
Net profit / Total profit (%)
Value100.00
Score0/3
Weight-0.33%
1M Return-0.30%
Value100.00
Score0/3
Weight-0.33%
1M Return-0.30%
Is LYEL fundamentally strong?
- LYEL scores 6.55/10 on fundamentals and holds a Discounted valuation at present. Backed by its -37.57% ROE, -794292.68% net margin, -1.46 P/E ratio, 1.47 P/B ratio, and -43.71% earnings growth, these metrics solidify its Outperform investment rating.
